Chapter
Developing medicines for rare diseases.
1:11:03 - 1:21:50 (10:47)
The economic challenge of developing a small range of drugs for diseases that only affect a limited number of individuals has started to be overcome with new technologies and faster manufacturing methods. Amicus was created to provide a caring and slow response to the needs of patients with rare diseases.
Clips
Developing drugs or treatments for rare diseases can be economically challenging due to the small number of patients affected by any given disease.
1:11:03 - 1:13:34 (02:31)
Summary
Developing drugs or treatments for rare diseases can be economically challenging due to the small number of patients affected by any given disease. However, with advancements in technology and regulatory science, economic models can be built to support diseases with 500 or more patients, enabling the development of meaningful treatments for those in need.
ChapterDeveloping medicines for rare diseases.
Episode#225: John Crowley -- The Real-Life Captain America and Bruce Banner (Seriously)
PodcastThe Tim Ferriss Show
John Crowley, the CEO of patient-centered bio-tech company Amicus, talks about why he named the company and shares his journey from being commissioned an officer in the navy reserve to starting Amicus Therapeutics.
1:13:35 - 1:17:38 (04:02)
Summary
John Crowley, the CEO of patient-centered bio-tech company Amicus, talks about why he named the company and shares his journey from being commissioned an officer in the navy reserve to starting Amicus Therapeutics.
ChapterDeveloping medicines for rare diseases.
Episode#225: John Crowley -- The Real-Life Captain America and Bruce Banner (Seriously)
PodcastThe Tim Ferriss Show
John Crowley, entrepreneur and veteran, shares insights from his career in biotech and the military.
1:17:38 - 1:21:50 (04:12)
Summary
John Crowley, entrepreneur and veteran, shares insights from his career in biotech and the military. He emphasizes the importance of persistence and resiliency, setting a clear vision, and breaking down barriers to success.